The Second Annual Pharmacogenetics in Psychiatry Meeting

			The Second Annual Pharmacogenetics in Psychiatry Meeting April 11 & 12, 2003 A Category 1 CME Conference Sponsored by the Department of Psychiatry Hillside Hospital Organizing Committee Anil K. Malhotra, MD James L. Kennedy, MD, CAMH John M. Kane, MD About the Program Pharmacogenetic strategies are increasingly being utilized to identify biological predictors of psychotropic drug response as well as to provide novel targets for psychotropic drug development. Consequently, the field of pharmacogenetics in psychiatry is rapidly developing within academia and the biotechnology and pharmaceutical industries. This meeting has been designed to provide a forum for a specific focus on developments in psychiatric pharmacogenetics. The Pharmacogenetics in Psychiatry Meeting includes sessions presenting the latest pharmacogenetics data from around the world. Topics will include: prediction of clinical response to the new antipsychotic drugs genes associated with the development of adverse side effects candidate gene studies of antidepressant response developments in the identification of candidate alleles for the action of the antianxiety agents novel statistical approaches to dissect the heterogeneity of drug response mircroarrays and new technologies Program Information   Dates: Friday, April 11, 2003 and Saturday, April 12, 2003 Location: New York City, NY Accommodations: A block of rooms will be reserved at a special rate in the winter of 2003. Rooms may be reserved during this time by contacting the venue (to be announced) directly.   Registration Contact: Department of Professional and Public Health Education at Long Island Jewish Health System Phone: (516) 465-2500 Fax: (516) 564-8204 e-mail: atruchan@nshs.edu Website: www.northshorelij.edu Cancellations All cancellations must be confirmed in writing by the middle of March 2003 for registration refund. An administrative fee of $25.00 will be retained after the March deadline (to be announced), or for 'no shows'. Accreditation North Shore-Long Island Jewish Health System is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. North Shore-Long Island Jewish Health System designates this continuing medical education activity for a maximum of 11 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. Abstracts Abstracts are invited for oral or poster presentation. Abstracts have no specific format, but should include the title of the presentation, the authors' names and affiliations, and no more than 250 words of text. Submissions should indicate the corresponding author's e-mail address, telephone and fax numbers and whether an oral or poster presentation is preferred. Abstract Submission Submission deadline will be in January 2003 (January date to be announced). E-mail: kusen@lij.edu (Word Perfect of Microsoft Word formats) Fax: Grace Kusen at (718) 343-1659   Abstract Information For more program information, call Grace Kusen, Program Coordinator, at (718) 470-8418. Registration PDF of this brochure and registration form Registration Fees Physicians and Scientists $100.00 Residents, Fellows, Students and Allied Health Professionals $ 50.00   Registration Methods Fax: Registration form with your Visa or MasterCard number to (516) 465-8204 Phone: (516) 465-2500 with your Visa or MasterCard number Mail: Check or Visa or MasterCard number to: Pharmacogenetics in Psychiatry Meeting North Shore-Long Island Jewish Health System Department of Professional and Public Health Education 125 Community Drive, Great Neck, NY 11021 Program Chair Anil K. Malhotra, MD, Associate Director, Psychiatry Research, Hillside Hospital of Long Island Jewish Medical Centre, Glen Oaks, NY Session Chairs David A. Collier, MD, Head, Section of Molecular Genetics, Institute of Psychiatry, London, United Kingdom David Goldman, MD, Chief, Laboratory of Neurogenetics, National Institute of Alcohol Abuse And Alcoholism, Rockville, MD   John M. Kane, MD, Chairman, Department of Psychiatry, Hillside Hospital of Long Island Jewish Medical Center, Glen Oaks, NY James L. Kennedy, MD, Head, Section of Neurogenetics, Centre for Addiction & Mental Health, Clarke Division, University of Toronto, Toronto, Canada, james_kennedy@camh.net     Further information on the 2nd Annual 'Pharmacogenetics in Psychiatry' meeting can be obtained by email from Dr. Anil Malhotra and/or Dr. James Kennedy		En Français | Help | Search | Events | CAMH Library | Guide to CAMH | Donate Now   You are Here : CAMH > Events> Second Annual Pharmacogenetics in Psychiatry Meeting Related Pages PDF of this brochure and registration form

			For further information, please contact: For general information on addiction and mental health: Call toll free in Ontario 1-800-463-6273 or local (416) 595-6111 DISCLAIMER: The Centre is not able to provide diagnostic, treatment or referral services through the Internet. Individuals should contact their family doctors, or their local mental health or addiction agency for further information.		© Copyright Centre for Addiction and Mental Health 33 Russell Street, Toronto Ontario, Canada M5S 2S1. Telephone: (416) 535-8501 The Centre is fully affiliated with the University of Toronto. A Pan American Health Organization and World Health Organization Collaborating Centre For inquiries regarding the content of this page, contact Please direct technical questions or comments about this site to If you are a spammer or spam-harvesting robot, please send mail to imaspammer-on@lists.camh.net.
			Home / About Addiction / About Mental Health / Community Health & Education / Research / CAMH Foundation / Education / CAMH Publications / Volunteers / Guide to CAMH / En francais / Help / Search this site / How to Reach Us / Donate Online Now

This page was last modified on Monday, March 10, 2003 4:51 PM